References
Klaassen KMG, van de Kerkhof PCM, Pasch MC. Nail psoriasis, the unknown burden of disease. J Eur Acad Dermatol Venereol 2014; 28: 1690–5.
Hawro M, Maurer M, Weller K, et al. Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis. J Am Acad Dermatol 2017; 76: 648–54.e2.
Alpsoy E, Polat M, FettahlioGlu-Karaman B, et al. Internalized stigma in psoriasis: a multicenter study. J Dermatol 2017; 44: 885–91.
Malakouti M, Brown GE, Leon A, et al. The dermatologic intimacy scale: quantitatively measuring the impact of skin disease on intimacy. J Dermatolog Treat 2017; 28: 347–52.
Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP. Extended report: nail disease in psoriatic arthritisclinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 2004; 43: 790–4.
Piraccini BM1, Starace M, Toft A. Early visible improvements during K101-03 treatment: an open-label multicenter clinical investigation in patients with onychomycosis and/or nail psoriasis. Dermatology 2017; 233: 178–83.
Augustin M, Reich K, Blome C, Schäfer I, Laass A, Radtke MA. Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol 2010; 163: 580–5.
Crowley JJ, Weinberg JM, Wu JJ, Robertson AD, Van Voorhees AS, & National Psoriasis Foundation. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation. JAMA Dermatol 2015; 151: 87–94.
Faergemann J, Gullstrand S, Rensfeldt K. Early and visible improvements after application of K101 in the appearance of nails discoloured and deformed by onychomycosis. J Cosmet Dermatol Sci Appl 2011; 1: 59–63.
Pan JY, Tan CL, Toft A. Rapid visible improvements in onychomycosis: an open-label clinical investigation of Kerasal NailTM. J Cosmet Dermatol Sci Appl 2017; 7: 57–66.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Piraccini, B.M., Starace, M. & Toft, A. Rapid cosmetic improvement in nail psoriasis patients treated with K101-03. Eur J Dermatol 28, 272–274 (2018). https://doi.org/10.1684/ejd.2018.3296
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2018.3296